Search | IOVS | ARVO Journals

Showing 1 – 20 of 24

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2015

Retinal Angiomatous Proliferation and Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

Ebenezer Daniel; Maureen G Maguire; James Shaffer; Gui-Shuang Ying; Juan E Grunwald; Glenn J Jaffe; Daniel F Martin; Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2833.

ARVO Annual Meeting Abstract June 2015

Petaloid Macular Edema and Outcomes in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Neepa Shah; Maureen G Maguire; Daniel F Martin; James Shaffer; Gui-Shuang Ying; Juan E Grunwald; Cynthia A Toth; Glenn J Jaffe; Ebenezer Daniel; CATT Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2847.

ARVO Annual Meeting Abstract June 2015

Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of AMD Treatments Trials (CATT)

Thomas A Ciulla; Gui-Shuang Ying; Maureen G Maguire; Daniel F Martin; Glenn J Jaffe; Juan E Grunwald; Ebenezer Daniel; Cynthia A Toth; CATT Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3154.

ARVO Annual Meeting Abstract June 2015

Resolution of Retinal Fluid on Optical Coherence Tomography in the Comparison of AMD Treatments Trials (CATT)

Maxwell Pistilli; Gui-Shuang Ying; Cynthia A Toth; Glenn J Jaffe; Daniel F Martin; CATT Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1657.

ARVO Annual Meeting Abstract June 2015

Association between Antiplatelet or Anticoagulant Drugs and Retinal Hemorrhage in the Comparison of AMD Treatments Trials (CATT)

Gui-Shuang Ying; Maureen G Maguire; Ebenezer Daniel; Juan E Grunwald; Daniel F Martin; CATT Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2569.

ARVO Annual Meeting Abstract April 2014

Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Sumit Sharma; Cynthia A Toth; Ebenezer Daniel; Juan E Grunwald; Maureen G Maguire; Gui-Shuang Ying; Daniel F Martin; Glenn J Jaffe; Comparison of Age-related Macular Degeneration Treatment Trials (CATT) Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1311.

ARVO Annual Meeting Abstract April 2014

Size and growth of geographic atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Juan E Grunwald; Maxwell Pistilli; Ebenezer Daniel; Gui-Shuang Ying; Stuart L Fine; Daniel F Martin; Maureen G Maguire; CATT Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1649.

ARVO Annual Meeting Abstract April 2014

Sporadic Visual Acuity Loss in the Comparison of AMD Treatments Trials (CATT)

Benjamin J Kim; Gui-Shuang Ying; Jiayan Huang; Nicole E Levy; Maureen G Maguire; CATT Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4962.

ARVO Annual Meeting Abstract April 2014

Impact of Change in Retinal Thickness on Refractive Error in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Jiayan Huang; Gui-Shuang Ying; Maureen G Maguire; Richard A Stone; Daniel F Martin; CATT Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):657.

ARVO Annual Meeting Abstract April 2014

Influence of SNPs Associated with Age-related Macular Degeneration (AMD) on the Phenotype of Neovascular Lesions in the Comparison of AMD Treatments Trials (CATT)

Maureen G Maguire; Stephanie A Hagstrom; Gui-Shuang Ying; CATT Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):865.

ARVO Annual Meeting Abstract April 2014

Visual Acuity Response Pattern and Prediction in the Comparison of AMD Treatments Trials (CATT)

Gui-Shuang Ying; Maureen G Maguire; Jiayan Huang; Daniel F Martin; CATT Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):866.

ARVO Annual Meeting Abstract April 2014

Predictors of the Number of Injections among Patients Treated PRN with Ranibizumab or Bevacizumab in the Comparison of AMD Treatments Trials (CATT)

Daniel F Martin; Gui-Shuang Ying; Jiayan Huang; Maureen G Maguire; CATT Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):869.

ARVO Annual Meeting Abstract June 2013

Incidence of Endophthalmitis after Anti-VEGF Injections and use of Anti-Microbials in the Comparison of AMD Treatments Trials (CATT)

Colin McCannel; Travis Meredith; Ellen Peskin; Maureen Maguire; Charles Barr; Beranrd Doft; Jonathan Prenner; CATT Research Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1114.

ARVO Annual Meeting Abstract June 2013

Geographic atrophy risk factors in participants of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Juan Grunwald; Ebenezer Daniel; Gui-Shuang Ying; Jiayan Huang; Glenn Jaffe; Cynthia Toth; Stephanie Hagstrom; Stuart Fine; Daniel Martin; Maureen Maguire; CATT Research Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3658.

ARVO Annual Meeting Abstract June 2013

Sustained Severe Visual Acuity Loss in the Comparison of AMD Treatments Trials (CATT)

Gui-Shuang Ying; Benjamin Kim; Maureen Maguire; Jiayan Huang; Ebenezer Daniel; Glenn Jaffe; Daniel Martin; Juan Grunwald; CATT Research Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3659.

ARVO Annual Meeting Abstract June 2013

Risk Factors for Scarring in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Ebenezer Daniel; Cynthia Toth; Juan Grunwald; Daniel Martin; Gui-Shuang Ying; Jiayan Huang; Glenn Jaffe; Stuart Fine; Maureen Maguire; CATT Research Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3661.

ARVO Annual Meeting Abstract June 2013

VEGF-A and VEGFR-2 Gene Polymorphisms and Response to Anti-VEGF Therapy in the Comparison of AMD Treatments Trials (CATT)

Stephanie Hagstrom; Gui-Shuang Ying; Gayle Pauer; Gwen Sturgill-Short; Jiayan Huang; Maureen Maguire; Daniel Martin; CATT Research Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):6187.

ARVO Annual Meeting Abstract June 2013

Comparison of spectral domain and time domain OCT for qualitative and quantitative fluid assessments in the Comparison of AMD Treatments Trials (CATT)

Francisco Folgar; Cynthia Toth; Gui-Shuang Ying; Maureen Maguire; Glenn Jaffe; Comparison of AMD Treatments Trials (CATT) Research Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):6291.

ARVO Annual Meeting Abstract March 2012

Comparison of RC and Investigator Determined Retinal and Subretinal fluid in the Comparison of Age-Related Macular Degeneration Treatment Trials (CATT)

Cynthia A. Toth; Francis C. DeCroos; Glenn J. Jaffe; Gui-Shuang Ying; Sandra S. Stinnett; Cynthia S. Heydary; Russell Burns; CATT Research Group

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2894.

ARVO Annual Meeting Abstract March 2012

Reproducibility of Optical Coherence Tomography Image Grading During the Comparisons of Age-Related Macular Degeneration Treatments Trials (CATT)

Francis C. DeCroos; Cynthia A. Toth; Sandra Stinnett; Cynthia S. Heydary; Russell Burns; Glenn J. Jaffe; CATT Research Group

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2895.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Specify Date Range

Retinal Angiomatous Proliferation and Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

Petaloid Macular Edema and Outcomes in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of AMD Treatments Trials (CATT)

Resolution of Retinal Fluid on Optical Coherence Tomography in the Comparison of AMD Treatments Trials (CATT)

Association between Antiplatelet or Anticoagulant Drugs and Retinal Hemorrhage in the Comparison of AMD Treatments Trials (CATT)

Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Size and growth of geographic atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Sporadic Visual Acuity Loss in the Comparison of AMD Treatments Trials (CATT)

Impact of Change in Retinal Thickness on Refractive Error in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Influence of SNPs Associated with Age-related Macular Degeneration (AMD) on the Phenotype of Neovascular Lesions in the Comparison of AMD Treatments Trials (CATT)

Visual Acuity Response Pattern and Prediction in the Comparison of AMD Treatments Trials (CATT)

Predictors of the Number of Injections among Patients Treated PRN with Ranibizumab or Bevacizumab in the Comparison of AMD Treatments Trials (CATT)

Incidence of Endophthalmitis after Anti-VEGF Injections and use of Anti-Microbials in the Comparison of AMD Treatments Trials (CATT)

Geographic atrophy risk factors in participants of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

Sustained Severe Visual Acuity Loss in the Comparison of AMD Treatments Trials (CATT)

Risk Factors for Scarring in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)

VEGF-A and VEGFR-2 Gene Polymorphisms and Response to Anti-VEGF Therapy in the Comparison of AMD Treatments Trials (CATT)

Comparison of spectral domain and time domain OCT for qualitative and quantitative fluid assessments in the Comparison of AMD Treatments Trials (CATT)

Comparison of RC and Investigator Determined Retinal and Subretinal fluid in the Comparison of Age-Related Macular Degeneration Treatment Trials (CATT)

Reproducibility of Optical Coherence Tomography Image Grading During the Comparisons of Age-Related Macular Degeneration Treatments Trials (CATT)

To View More...

You must be signed into an individual account to use this feature.